Home › Metastatic Cancer › Missouri › St. Louis
Pag-aaral pangklinika para sa Metastatic Cancer sa St. Louis, MO
54 pag-aaral para sa Metastatic Cancer ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng St. Louis (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Nagre-recruitPhase 2
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- at 6 pa
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- Washington University Medicine, St Louis
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
Nagre-recruitPhase 1
- Washington University School of Medicine, St Louis
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Nagre-recruitPhase 1
- Washington University School of Medicine in St. Louis, St Louis
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Nagre-recruitPhase 1
- Washington University School of Medicine, St Louis
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Nagre-recruitPhase 1
- Washington University School of Medicine, St Louis
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
Nagre-recruitPhase 1/2
- Washington University in St. Louis, St Louis
A Study of ASP3082 in Adults With Advanced Solid Tumors
Nagre-recruitPhase 1
- Washington University School of Medicine, St Louis
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Nagre-recruitPhase 2/3
- Siteman Cancer Center, St Louis
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Nagre-recruitPhase 3
- Research Site, St Louis
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Nagre-recruitPhase 2
- Washington University School of Medicine- Siteman Cancer Center, St Louis
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Nagre-recruitPhase 1/2
- Washington University School of Medicine in St. Louis, St Louis
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Nagre-recruitPhase 2/3
- Cancer Care Specialists of Illinois - Cancer Care Center of O'Fallon, O'Fallon · 16 mi ang layo
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Nagre-recruitPhase 1/2
- Washington University School of Medicine, St Louis
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Nagre-recruitPhase 1
- Washington University, St Louis
SLV-154 Treatment of Advanced Cancers
Nagre-recruitPhase 1
- Washington University, St Louis
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Nagre-recruitPhase 3
- Washington University School of Medicine, St Louis
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Nagre-recruitPhase 2
- Siteman Cancer Center (Washington University School of Medicine), St Louis
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Nagre-recruitPhase 1/2
- Washington University, St Louis
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Nagre-recruitPhase 1/2
- Siteman Cancer Center, St Louis
- Barnes-Jewish Hospital, St Louis
- Washington University School of Medicine - Siteman Cancer Center, St Louis
- at 5 pa
A Study of KK2269 in Adult Participants With Solid Tumors
Nagre-recruitPhase 1
- Washington University, St Louis
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
- Washington University School of Medicine, St Louis
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Nagre-recruitPhase 1
- Siteman Cancer Center at Washington University, St Louis
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
Nagre-recruitPhase 2
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- at 1 pa
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1
- Washington University, St Louis
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Nagre-recruitPhase 1
- Washington University in St. Louis, St Louis
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Washington University School of Medicine, St Louis
IDOV-Immune for Advanced Solid Tumors
Nagre-recruitPhase 1
- Washington University School of Medicine, St Louis
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Washington University, St Louis
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- Investigative Site #110, St Louis
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- Investigative Site #110, St Louis
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Washington University, St Louis
Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
Nagre-recruitPhase 1
- Washington University School of Medicine, St Louis
A Study of PYX-201 in Advanced Solid Tumors
Nagre-recruitPhase 1
- Washington University School of Medicine, St Louis
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Nagre-recruitPhase 3
- University of Kansas Cancer Center - Overland Park, Overland · 10 mi ang layo
A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- Exelixis Clinical Site #6, St Louis
A Study of LY4175408 in Participants With Advanced Cancer
Nagre-recruitPhase 1
- Washington University, St Louis
REMASTer: REcurrent Brain Metastases After SRS Trial
Nagre-recruit
- WashU, St Louis
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
Nagre-recruitPhase 3
- Washington University, St Louis
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Nagre-recruitPhase 2
- VA St. Louis Health Care System, St Louis
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- Research Site, St Louis
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Nagre-recruitPhase 1
- Research Site, St Louis
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Nagre-recruitPhase 1/2
- Washington University School of Medicine Siteman Cancer Center, St Louis
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Nagre-recruitPhase 3
- Washington University School of Medicine in Saint Louis, St Louis
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Nagre-recruitPhase 1
- Washington University School of Medicine, St Louis
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Nagre-recruitPhase 2/3
- Washington University School of Medicine in St. Louis, St Louis
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Nagre-recruitPhase 1/2
- Washington University School of Medicine, St Louis
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Nagre-recruitPhase 3
- Siteman Cancer Center - Washington University, St Louis
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
Nagre-recruitObservasyonal na pag-aaral
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- Mercy Hospital Saint Louis, St Louis
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
Nagre-recruitPhase 1
- Washington University, St Louis
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Washington University, St Louis
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
Nagre-recruitPhase 3
- The Washington University, St Louis
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Nagre-recruitPhase 1
- Washington University Medical Campus, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, St Louis
Pag-aaral para sa Metastatic Cancer sa ibang lungsod
- Houston, TX104 pag-aaral
- New York City, NY93 pag-aaral
- Nashville, TN70 pag-aaral
- Boston, MA63 pag-aaral
- Los Angeles, CA57 pag-aaral
- Arlington, VA53 pag-aaral
- Philadelphia, PA46 pag-aaral
- Chicago, IL45 pag-aaral
- San Antonio, TX44 pag-aaral
- Washington, DC43 pag-aaral
- Dallas, TX42 pag-aaral
- Seattle, WA39 pag-aaral
Iba pang pag-aaral sa St. Louis
- Non-Small Cell Lung Cancer73 pag-aaral
- Kanser sa Suso64 pag-aaral
- Colorectal Cancer50 pag-aaral
- Kanser (lahat ng uri)46 pag-aaral
- Kanser sa Prostate46 pag-aaral
- Kanser sa Baga39 pag-aaral
- Kanser sa Ovary38 pag-aaral
- Kanser sa Pancreas33 pag-aaral
- Kanser ng Endometrium29 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg28 pag-aaral
- Pagkabigo ng Puso26 pag-aaral
- Obesity25 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.